Her scientific interests lie mostly in Internal medicine, Transplantation, Surgery, Gastroenterology and Hematopoietic stem cell transplantation. Her Internal medicine study frequently links to adjacent areas such as Oncology. The study incorporates disciplines such as Retrospective cohort study, Hematology, Immunology and Hazard ratio in addition to Transplantation.
Her Surgery research incorporates elements of Incidence and Risk factor. Her research in Gastroenterology intersects with topics in Cord blood, Cyclophosphamide, Busulfan, Transplantation Conditioning and Acute lymphocytic leukemia. Her Hematopoietic stem cell transplantation research is multidisciplinary, incorporating elements of Survival rate, Autoimmune disease, Clinical endpoint, Randomization and Pediatrics.
The scientist’s investigation covers issues in Internal medicine, Transplantation, Acute leukemia, Oncology and Hematopoietic stem cell transplantation. Her Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Surgery. Her research investigates the connection with Surgery and areas like Bone marrow which intersect with concerns in Haematopoiesis.
Her Transplantation study combines topics from a wide range of disciplines, such as Regimen, Cyclophosphamide, Cumulative incidence and Hazard ratio. She combines subjects such as Busulfan, Marrow transplantation, Total body irradiation, Transplantation Conditioning and Cohort with her study of Acute leukemia. Her Hematopoietic stem cell transplantation study combines topics in areas such as Survival rate, Retrospective cohort study, Immunology, Human leukocyte antigen and Pediatrics.
Myriam Labopin mainly focuses on Internal medicine, Transplantation, Oncology, Acute leukemia and Myeloid leukemia. Her Internal medicine study frequently intersects with other fields, such as Gastroenterology. The various areas that Myriam Labopin examines in her Transplantation study include Cumulative incidence, Disease, Retrospective cohort study and Hazard ratio.
Her work in Oncology addresses issues such as Cohort, which are connected to fields such as Cohort study. Her studies deal with areas such as Minimal residual disease, Lymphoblastic Leukemia, Karnofsky Performance Status and Marrow transplantation as well as Acute leukemia. Her Myeloid leukemia research incorporates themes from Regimen and Fludarabine.
Myriam Labopin mostly deals with Internal medicine, Transplantation, Oncology, Acute leukemia and Myeloid leukemia. Her research in Hematopoietic stem cell transplantation, Leukemia, Cyclophosphamide, Incidence and Hazard ratio are components of Internal medicine. Her study in the fields of Graft-versus-host disease under the domain of Transplantation overlaps with other disciplines such as Sibling.
Her Oncology research is multidisciplinary, relying on both Complete remission, Chemotherapy, Secondary Acute Myeloid Leukemia and Risk factor. The concepts of her Acute leukemia study are interwoven with issues in Minimal residual disease, Total body irradiation and Marrow transplantation. Her biological study spans a wide range of topics, including Regimen, Randomized controlled trial and Fludarabine, Treosulfan.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT).
M. Aoudjhane;M. Labopin;N. C. Gorin;A. Shimoni.
Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party
Christoph Schmid;Myriam Labopin;Arnon Nagler;Martin Bornhäuser.
Journal of Clinical Oncology (2007)
Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases
Dominique Farge;Myriam Labopin;Alan Tyndall;Athanasios Fassas.
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation
Fabio Ciceri;Myriam Labopin;Franco Aversa;Jakob M. Rowe.
Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis
Salut Brunet;Myriam Labopin;Jordi Esteve;Jan Cornelissen.
Journal of Clinical Oncology (2012)
Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome
V. Runde;T.J.M. de Witte;R. Arnold;A. Gratwohl.
Bone Marrow Transplantation (1998)
Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation.
Mohamad Mohty;Myriam Labopin;Liisa Volin;Alois Gratwohl.
Treatment With Granulocyte Colony-Stimulating Factor After Allogeneic Bone Marrow Transplantation for Acute Leukemia Increases the Risk of Graft-Versus-Host Disease and Death: A Study From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Olle Ringdén;Myriam Labopin;Norbert Claude Gorin;Katarina Le Blanc.
Journal of Clinical Oncology (2004)
Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group
Thomas Klingebiel;Jacqueline Cornish;Myriam Labopin;Franco Locatelli.
Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time - a report of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
F. Frassoni;M. Labopin;E. Gluckman;H.G. Prentice.
Bone Marrow Transplantation (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: